Neo Ivy Capital Management Amicus Therapeutics, Inc. Transaction History

Neo Ivy Capital Management

  • $497 Million
  • Q4 2024

A detailed history of Neo Ivy Capital Management transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Neo Ivy Capital Management holds 395,745 shares of FOLD stock, worth $3.64 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
395,745
Previous 65,786 501.56%
Holding current value
$3.64 Million
Previous $702,000 430.91%
% of portfolio
0.75%
Previous 0.24%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 18, 2025
BUY
$9.36 - $12.01 $3.09 Million - $3.96 Million
329,959 Added 501.56%
395,745 $3.73 Million
Q3 2024

Nov 15, 2024
BUY
$9.55 - $12.09 $628,256 - $795,352
65,786 New
65,786 $702,000
Q3 2023

Nov 29, 2023
SELL
$11.78 - $13.86 $248,251 - $292,085
-21,074 Reduced 77.14%
6,244 $76,000
Q2 2023

Aug 15, 2023
BUY
$10.72 - $13.3 $186,913 - $231,898
17,436 Added 176.44%
27,318 $343,000
Q4 2022

Mar 24, 2023
BUY
$9.89 - $12.7 $97,732 - $125,501
9,882 New
9,882 $120,000
Q2 2022

Aug 16, 2022
SELL
$6.23 - $11.12 $20,671 - $36,896
-3,318 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$7.89 - $12.48 $14,706 - $23,262
1,864 Added 128.2%
3,318 $32,000
Q4 2021

Feb 15, 2022
SELL
$9.82 - $12.44 $15,888 - $20,127
-1,618 Reduced 52.67%
1,454 $16,000
Q3 2021

Nov 16, 2021
SELL
$8.74 - $11.84 $292,982 - $396,900
-33,522 Reduced 91.61%
3,072 $46,000
Q2 2021

Aug 16, 2021
BUY
$8.71 - $10.72 $318,733 - $392,287
36,594 New
36,594 $353,000
Q1 2021

Oct 07, 2021
SELL
$9.2 - $23.86 $56,837 - $147,407
-6,178 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$13.47 - $24.89 $43,130 - $79,697
3,202 Added 107.59%
6,178 $143,000
Q3 2020

Nov 17, 2020
SELL
$12.89 - $15.89 $18,974 - $23,390
-1,472 Reduced 33.09%
2,976 $42,000
Q2 2020

Aug 17, 2020
SELL
$8.86 - $15.69 $110,067 - $194,916
-12,423 Reduced 80.17%
3,072 $46,000
Q2 2020

Aug 17, 2020
BUY
$8.86 - $15.69 $12,191 - $21,589
1,376 Added 44.79%
4,448 $67,000
Q1 2020

May 15, 2020
BUY
$6.63 - $11.16 $27,494 - $46,280
4,147 Added 36.54%
15,495 $143,000
Q4 2019

Feb 13, 2020
BUY
$7.48 - $10.75 $84,883 - $121,991
11,348 New
11,348 $111,000
Q3 2019

Nov 21, 2019
SELL
$8.02 - $13.25 $35,672 - $58,936
-4,448 Closed
0 $0
Q2 2019

Aug 15, 2019
BUY
$10.96 - $14.4 $2,761 - $3,628
252 Added 6.01%
4,448 $56,000
Q1 2019

May 15, 2019
BUY
$10.04 - $13.92 $42,127 - $58,408
4,196 New
4,196 $57,000

Others Institutions Holding FOLD

# of Institutions
312
Shares Held
311M
Call Options Held
467K
Put Options Held
515K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.58B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Neo Ivy Capital Management Portfolio

Follow Neo Ivy Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Neo Ivy Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email